Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The predisposition for scleroderma, defined as fibrosis and hardening of the skin, is poorly understood. We report that stiff skin syndrome (SSS), an autosomal dominant congenital form of scleroderma, is caused by mutations in the sole Arg-Gly-Asp sequence-encoding domain of fibrillin-1 that mediates integrin binding. Ordered polymers of fibrillin-1 (termed microfibrils) initiate elastic fiber assembly and bind to and regulate the activation of the profibrotic cytokine transforming growth factor-beta (TGFbeta). Altered cell-matrix interactions in SSS accompany excessive microfibrillar deposition, impaired elastogenesis, and increased TGFbeta concentration and signaling in the dermis. The observation of similar findings in systemic sclerosis, a more common acquired form of scleroderma, suggests broad pathogenic relevance.

Original publication




Journal article


Sci Transl Med

Publication Date





Biopsy, Cell Adhesion, Cell Movement, Collagen, DNA Mutational Analysis, Elastin, Extracellular Matrix, Family, Female, Fibrillin-1, Fibrillins, Humans, Immunohistochemistry, Male, Mesoderm, Microfibrils, Microfilament Proteins, Mutation, Pedigree, Phenotype, Scleroderma, Systemic, Signal Transduction, Skin, Syndrome, Transforming Growth Factor beta